447
Participants
Start Date
July 31, 2004
Primary Completion Date
December 31, 2008
Study Completion Date
August 31, 2011
ZD4054 15 mg
15 mg oral tablet once daily
Placebo
ZD4054 10 mg
10mg oral tablet once daily
Research Site, Tucson
Research Site, Los Angeles
Research Site, Gainsville
Research Site, Chicago
Research Site, Baltimore
Research Site, Cleveland
Research Site, Simpsonville
Research Site, Wolloongabba
Research Site, Ashford
Research Site, Wodonga
Research Site, Nedlands
Research Site, Brussels
Research Site, Ghent
Research Site, Leuven
Research site, Vancouver
Research site, London
Research site, Toronto
Research site, Montreal
Research site, Québec
Research Site, Aarhus
Research Site, Herlev
Research Site, Helsinki
Research Site, Joensuu
Research Site, OYS
Research Site, Seinäjoki
Research Site, Tampere
Research Site, Lille
Research Site, Montpellier
Research Site, Paris
Research site, Pontoise
Research Site, Toulouse
Research Site, Jakarta
Research Site, Eindhoven
Research Site, Groningen
Research Site, Heerlen
Research Site, Leiden
Research Site, Rotterdam
Research Site, Utrecht
Research Site, Bergen
Research Site, Fredrikstad
Research Site, Moelv
Research Site, Oslo
Research Site, Tromsø
Research Site, Trondheim
Research Site, Tønsberg
Research Site, Bydgoszcz
Research Site, Katowice
Research Site, Warsaw
Research Site, Gothenburg
Research Site, Malmo
Research Site, Stockholm
Research Site, Geneva
Research Site, Locarno
Research Site, Birmingham
Research Site, Leeds
Research Site, London
Research Site, Maidstone
Research Site, Manchester
Research Site, Newcastle
Research Site, York
Lead Sponsor
AstraZeneca
INDUSTRY